Is this you? As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work.
Claim your profile
Abstract Aims The Cardiac Lipid Panel (CLP) is a newly discovered panel of metabolite‐based biomarkers that has shown to improve the diagnostic value of N terminal pro B type natriuretic peptide (NT‐proBNP). However, little is known about its usefulness in predicting outcomes. In this study, we developed a risk score for 4‐year cardiovascular death in elderly chronic heart failure (CHF) patients using the CLP.
Further, serial biomarker measurement in HF management has received growing interest for outcome prediction. 15 , 16 However, most authors assessed biomarkers only on admission and pointed out rare time points to re‐measure, for example, prior to discharge. 7 Indeed, little is known about the exact trajectory of biomarkers during an episode of decompensation, and there has not been a comparison of the prognostic performance of serial measurements.
As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work.
